Skip to main content
Questions about giving or our research? Call us — (800) 321-2873 Donor help Search

by
Blog
March 27, 2019

[vc_row][vc_column width="1/4"][vc_single_image image="25393" img_size="large" alignment="center" style="vc_box_shadow_border" css=""][/vc_column][vc_column width="3/4"][vc_column_text css=""] “It was a great pleasure because it is so important,” recalls Carlo Croce, M.D., of his 2008 win of the National Foundation for Cancer Research’s Szent-Györgyi Prize for Progress in Cancer Research. “The committee is very selective,...

by
Blog
February 21, 2019

[vc_row][vc_column][vc_single_image image="25770" img_size="full" add_caption="yes" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""] “I was attracted, even as a youngster, by infectious diseases and cancer,” recalls Alex Matter, M.D. That young boy would pursue these passions and, in adulthood, emerge as a leading global authority in the disease field. Now the CEO of...

by
ASG, ASG News, Blog, Press Release
February 12, 2019

FOR IMMEDIATE RELEASE: February 12, 2019 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 Awardee Has Remained at the Vanguard of Various Cancer Immunotherapy Fields for over Four Decades ROCKVILLE, MD - The National Foundation for Cancer Research...

by
Blog
January 10, 2019

[vc_row][vc_column][vc_single_image image="14232" img_size="full" add_caption="yes" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]Cancer is complex. “Simple” is the last word that either layman or scientist would use to describe virtually any aspect of the disease. However, simply put, the health prospects of women worldwide have improved as a result of the...

,

by
Blog, Cancer Prevention
January 2, 2019

[vc_row][vc_column][vc_single_image image="24293" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]The U.S. Food and Drug Administration (FDA) recently approved Gardasil 9, a human papilloma virus (HPV) vaccine, for adults aged 27 to 45. The move could help further spell the end of one of the main causes of a host...

, , ,

by
Blog
October 4, 2018

“How wonderful that we have met with a paradox. Now we have some hope of making progress.” The words of acclaimed physicist Niels Bohr can be thought to apply to the somewhat counterintuitive notion that by engineering an element of the human body’s wondrous natural defense...